Home » Newsletters » BioWorld Science

BioWorld Science

May 15, 2020

View Archived Issues

Liver-specific pre-eclampsia treatment is maternal-specific

Novadip reports interim data from phase I/II bone non-union study of NVD-003

Advaxis reports positive preliminary data from ongoing phase I/II study of ADXS-503 in NSCLC

Abivax receives clearance to initiate phase IIb/III study of ABX-464 COVID-19 patients

FDA approves IND application for SMP-100 as treatment of IBS

Krystal Biotech announces positive interim data from phase I/II study of KB-105

Kaleido initiates developmental program of KB-109 in mild to moderate COVID-19

SHR-170008 immunotherapy demonstrates antitumor efficacy in vivo

Pharmacodynamic and safety data presented for emixustat

Researchers identify AMRC-835 for MBL-positive Gram-negative bacterial infections

Phase II/III data support potential of rAAV2-ND4 gene therapy in patients with LHON

Daiichi Sankyo, Sanford Burnham Prebys patent AP-TNAP inhibitors

Taiho Pharmaceutical discloses mutant GTPase KRAS inhibitors

New factor XIa and/or kallikrein B inhibitors identified at Merck & Co.

Bristol-Myers Squibb discovers Toll-like receptor antagonists

New kappa opioid receptor agonists synthesized at Nippon Chemiphar

Doubling down on edits keeps type 1 diabetes in check

EGFR identified as a target in some retinoblastoma tumors

MCo-PG1 shows good efficacy in Pseudomonas aeruginosa-driven sepsis model

European Commission approves Adcetris for previously untreated sALCL

Enzychem cleared to begin Korean phase II study with EC-18 to prevent ARDS in COVID-19

Danish study to evaluate iloprost in COVID-19 patients with ARDS

FDA accepts IND for iNKT therapy agenT-797 for cancer

Lyfaquin approved in India for hypovolemic shock

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...